Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
10.68
-0.31 (-2.82%)
Nov 20, 2024, 4:00 PM EST - Market closed
Atara Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | - | -276.13 | -228.3 | -340.14 | -306.62 | -290.98 | Upgrade
|
| Depreciation & Amortization | - | 4.83 | 5.65 | 9.35 | 8.33 | 7.14 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -50.24 | - | - | 1.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0.79 | 1.02 | 1.77 | 0.83 | -1.33 | Upgrade
|
| Stock-Based Compensation | - | 45.39 | 53.84 | 53.87 | 51.35 | 51.7 | Upgrade
|
| Other Operating Activities | - | 16.8 | 9.06 | 2.06 | 1.67 | 0.96 | Upgrade
|
| Change in Accounts Receivable | - | 6.11 | -39.24 | 0.26 | -1.25 | - | Upgrade
|
| Change in Inventory | - | -8.12 | -1.59 | - | - | - | Upgrade
|
| Change in Accounts Payable | - | -3.13 | -9.21 | 9.07 | -0.82 | 4.21 | Upgrade
|
| Change in Unearned Revenue | - | 30.4 | -11.47 | 35.22 | 61.25 | - | Upgrade
|
| Change in Other Net Operating Assets | - | -9.92 | 0.03 | 8.04 | 4.5 | -8.36 | Upgrade
|
| Operating Cash Flow | - | -192.98 | -270.43 | -220.52 | -180.76 | -235.63 | Upgrade
|
| Capital Expenditures | - | -1.22 | -4.19 | -10.58 | -4.51 | -5.73 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.03 | 94.77 | - | - | 0.16 | Upgrade
|
| Investment in Securities | - | 125.06 | 112.38 | 32.84 | -116.22 | 66.03 | Upgrade
|
| Investing Cash Flow | - | 123.87 | 202.96 | 22.26 | -120.73 | 60.46 | Upgrade
|
| Long-Term Debt Issued | - | - | 30.61 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.95 | -0.52 | -0.25 | -0.39 | -0.49 | Upgrade
|
| Net Debt Issued (Repaid) | - | -0.95 | 30.09 | -0.25 | -0.39 | -0.49 | Upgrade
|
| Issuance of Common Stock | - | 3.06 | 23.81 | 105.46 | 429.65 | 195.97 | Upgrade
|
| Repurchase of Common Stock | - | -0.09 | -0.62 | -1.24 | -1.52 | -6.7 | Upgrade
|
| Other Financing Activities | - | -0.01 | -0.19 | -0.02 | -0.17 | - | Upgrade
|
| Financing Cash Flow | - | 2.01 | 53.08 | 103.94 | 427.57 | 188.79 | Upgrade
|
| Net Cash Flow | - | -67.1 | -14.39 | -94.32 | 126.09 | 13.62 | Upgrade
|
| Free Cash Flow | - | -194.2 | -274.62 | -231.1 | -185.27 | -241.36 | Upgrade
|
| Free Cash Flow Margin | - | -2265.25% | -431.98% | -1136.19% | - | - | Upgrade
|
| Free Cash Flow Per Share | - | -45.84 | -67.32 | -61.68 | -62.61 | -117.60 | Upgrade
|
| Cash Interest Paid | - | 0.45 | 0.34 | 0.03 | 0.06 | 0.05 | Upgrade
|
| Cash Income Tax Paid | - | 0 | 0.02 | 0.02 | 0.01 | - | Upgrade
|
| Levered Free Cash Flow | - | -55.72 | -192.99 | -128.98 | -100.96 | -137.95 | Upgrade
|
| Unlevered Free Cash Flow | - | -52.42 | -192.76 | -128.98 | -100.96 | -137.95 | Upgrade
|
| Change in Net Working Capital | -81.81 | -66.89 | 76.47 | -31.18 | -37.02 | 6.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.